Stay updated with breaking news from Thomasm Soloway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment of severe allergy
Investegate announcements from T-knife Therapeutics, T-knife Therapeutics Announces New TCR-T Program Targeting KRAS G12V and Presents Data at the American Association for Cancer Research (AACR) Annual Meeting
SAN FRANCISCO, April 08, 2022. "This is an eventful year for T-knife, filled with meaningful corporate milestones," stated Thomas M. Soloway, Chief Executive Officer of T-knife. "Today's announcement
Investegate announcements from T-knife Therapeutics, T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel
Investegate announcements from T-knife Therapeutics, T-knife Therapeutics Appoints Biotech Industry Veteran Laura Brege to its Board of Directors